LYELL IMMUNOPHARMA INC shareholders Q3 2023

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.

LYELL IMMUNOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Adero Partners, LLC 20,869$30,6770.00%
TD ASSET MANAGEMENT INC 916,232$1,346,8610.00%
E Fund Management Co., Ltd. 21,829$320.00%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 150,866$221,7730.00%
IEQ CAPITAL, LLC 82,157$120,7710.00%
Verition Fund Management LLC 35,000$51,4500.00%
BlackRock Inc. 13,420,242$19,727,7560.00%
Baillie Gifford 732,636$1,076,9750.00%
Tower Research Capital LLC (TRC) 29,184$42,9000.00%
Ameritas Investment Partners, Inc. 17,114$25,1580.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,250,711$1,838,5450.00%
VANGUARD GROUP INC 16,909,720$24,857,2880.00%
PRICE T ROWE ASSOCIATES INC /MD/ 6,686,197$9,8300.00%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1,363,190$2,003,8890.00%
GEODE CAPITAL MANAGEMENT, LLC 3,656,483$5,375,6410.00%
MetLife Investment Management, LLC 92,101$135,3880.00%
STATE STREET CORP 6,810,428$10,011,3290.00%
CANADA PENSION PLAN INVESTMENT BOARD 588,235$864,7050.00%
METROPOLITAN LIFE INSURANCE CO/NY 9,849$14,4780.00%
AMERICAN INTERNATIONAL GROUP, INC. 86,607$127,3120.00%
External links

This page lists LYELL IMMUNOPHARMA INC's shareholders in Q3 2023. To view LYELL IMMUNOPHARMA INC's shareholder history, click here.